WhiteLab Genomics

BiotechnologySeries BEvry-courcouronnes, Francewhitelabgx.com

Latest round

Series B

Last raised

Oct 2026

Total raised

$29M

Investors

6

About WhiteLab Genomics

Based in France, and founded in 2019, WhiteLab Genomics SAS develops genomic medicine through machine learning and deep learning algorithms. The company was founded by its CEO David Del Bourgo, and CSO Julien Cottineau.Club and Yaday. Whitelab Genomics develops, designs, and offers various genomic therapies, including DNA, cell therapy, and RNA therapies, with the help of machine learning and deep learning algorithms. The company offers its software solutions and genomic therapies in the applications of target discovery, payload design, and vector design. The company’s artificial intelligence (AI) engine uses datasets to provide in-silico predictions.

Who invested in WhiteLab Genomics

6 investors across 2 rounds

See all investors in WhiteLab Genomics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 6, 2026

    Amount

    $26M

    Investors

    Locked

  2. Series A

    Apr 21, 2023

    Amount

    $2.7M

    Investors

    Locked

Questions about WhiteLab Genomics

Who invested in WhiteLab Genomics?

WhiteLab Genomics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has WhiteLab Genomics raised?

WhiteLab Genomics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did WhiteLab Genomics last raise money?

WhiteLab Genomics's most recent round on record is a Series B, in Oct 2026.

What does WhiteLab Genomics do?

Based in France, and founded in 2019, WhiteLab Genomics SAS develops genomic medicine through machine learning and deep learning algorithms.

Where is WhiteLab Genomics headquartered?

WhiteLab Genomics is headquartered in Evry-courcouronnes, France.

Which VCs invest in companies like WhiteLab Genomics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at WhiteLab Genomics's stage. Their profiles are linked below.

Raising like WhiteLab Genomics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.